Ares Acquisition [AACT] vs Cartesian Growth [RENEW] Detailed Stock Comparison
Ares Acquisition
NYSE
Loading...
Cartesian Growth
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 15 vital metrics comparison: Ares Acquisition wins in 2 metrics, Cartesian Growth wins in 6 metrics, with 2 ties. Cartesian Growth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ares Acquisition | Cartesian Growth | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.84 | N/A | N/A |
| Price-to-Book Ratio | 1.07 | N/A | N/A |
| Debt-to-Equity Ratio | 0.01 | 0.10 | Ares Acquisition |
| PEG Ratio | 1.85 | N/A | N/A |
| EV/EBITDA | -24.04 | -950.56 | Cartesian Growth |
| Profit Margin (TTM) | 0.00% | 0.00% | Tie |
| Operating Margin (TTM) | 0.00% | 0.00% | Tie |
| Return on Equity | 4.92% | 12.76% | Cartesian Growth |
| Return on Assets (TTM) | -0.46% | -0.50% | Ares Acquisition |
| Free Cash Flow (TTM) | $-929,804 | $-814,232 | Cartesian Growth |
| 1-Year Return | 6.05% | 9.82% | Cartesian Growth |
| Enterprise Value | $710.16M | $1.86B | Cartesian Growth |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $0.37 | N/A | N/A |
| Beta (Stock Volatility) | -0.01 | -0.01 | Cartesian Growth |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ares Acquisition vs Cartesian Growth Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ares Acquisition | 0.09% | -0.09% | 0.71% | 1.24% | 3.26% | 3.92% |
| Cartesian Growth | -0.27% | -0.08% | 0.45% | 10.13% | 25.17% | 22.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ares Acquisition | 6.05% | 12.66% | 12.66% | 12.66% | 12.66% | 12.66% |
| Cartesian Growth | 9.82% | 1,630.24% | 1,956.23% | 1,956.23% | 1,956.23% | 1,956.23% |
Performance & Financial Health Analysis: Ares Acquisition vs Cartesian Growth
| Metric | AACT | RENEW |
|---|---|---|
| Market Information | ||
| Market Cap | $705.82M | $1.85B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 363,510 | 1,113 |
| 90 Day Avg. Volume | 313,667 | 371 |
| Last Close | $11.40 | $141.49 |
| 52 Week Range | $10.73 - $11.62 | $110.08 - $147.87 |
| % from 52W High | -1.89% | -4.31% |
| All-Time High | $11.62 (Jun 02, 2025) | $147.87 (Jul 23, 2025) |
| % from All-Time High | -1.89% | -4.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | -0.53% | -0.70% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.00% |
| Operating Margin (TTM) | 0.00% | 0.00% |
| Return on Equity (TTM) | 0.05% | 0.13% |
| Debt to Equity (MRQ) | 0.01 | 0.10 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.40 | $-1.56 |
| Cash per Share (MRQ) | $0.01 | $0.02 |
| Operating Cash Flow (TTM) | $-986,029 | $-814,232 |
| Levered Free Cash Flow (TTM) | $523,595 | $-425,497 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Ares Acquisition vs Cartesian Growth
| Metric | AACT | RENEW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.84 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | 1.85 | N/A |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 1.07 | N/A |
| Market Capitalization | ||
| Market Capitalization | $705.82M | $1.85B |
| Enterprise Value | $710.16M | $1.86B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | -24.04 | -950.56 |
| Risk & Other Metrics | ||
| Beta | -0.01 | -0.01 |
| Book Value per Share (MRQ) | $-0.40 | $-1.56 |
Financial Statements Comparison: Ares Acquisition vs Cartesian Growth
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AACT | RENEW |
|---|---|---|
| Revenue/Sales | $0 | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-2.71M | $-195,387 |
| EBITDA | $-8.40M | $-273,251 |
| Pre-Tax Income | $2.99M | $559,864 |
| Income Tax | N/A | N/A |
| Net Income (Profit) | $2.99M | $559,864 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AACT | RENEW |
|---|---|---|
| Cash & Equivalents | $657,314 | $81,252 |
| Total Current Assets | $747,611 | $285,087 |
| Total Current Liabilities | $3.09M | $3.97M |
| Long-Term Debt | $5.00M | $4.48M |
| Total Shareholders Equity | $531.65M | $64.86M |
| Retained Earnings | $-24.75M | $-20.82M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AACT | RENEW |
|---|---|---|
| Operating Cash Flow | $2.99M | $-117,523 |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-318,005 | $-155,448 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AACT | RENEW |
|---|---|---|
| Shares Short | 73,299 | N/A |
| Short Ratio | 0.26 | N/A |
| Short % of Float | 0.00% | N/A |
| Average Daily Volume (10 Day) | 363,510 | 1,113 |
| Average Daily Volume (90 Day) | 313,667 | 371 |
| Shares Outstanding | 62.50M | 13.00M |
| Float Shares | 44.59M | 5.31M |
| % Held by Insiders | 0.20% | N/A |
| % Held by Institutions | 0.82% | N/A |
Dividend Analysis & Yield Comparison: Ares Acquisition vs Cartesian Growth
| Metric | AACT | RENEW |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.01 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $0.02 |
| Ex-Dividend Date | N/A | Dec 01, 2022 |